منابع مشابه
Effects of left ventricular assist device therapy on ventricular arrhythmias.
OBJECTIVES In a retrospective study, we sought to evaluate the effect of left ventricular assist device (LVAD) therapy on ventricular tachyarrhythmias in patients with advanced congestive heart failure. BACKGROUND Despite the increasing use of LVAD as a bridge to cardiac transplantation, our knowledge regarding its effect on ventricular arrhythmias is currently limited to small series. Little...
متن کاملLeft ventricular assist device therapy improves utilization of donor hearts.
OBJECTIVES We sought to determine the survival experiences of patients bridged to heart transplantation with either intravenous (IV) inotropes or an implantable left ventricular assist device (LVAD). BACKGROUND Because of the operative risks of LVAD implantation and the reported lower mortality associated with inotropic therapy, bridging to heart transplantation with inotropes is thought to b...
متن کاملPatient-Reported Outcomes in Left Ventricular Assist Device Therapy
Background—Technological advancements of left ventricular assist devices (LVAD) have created today’s potential for extending the lives of patients with end-stage heart failure. Few studies have examined the effect of LVAD therapy on patient-reported outcomes (PROs), such as health status, quality of life, and anxiety/depression, despite poor PROs predicting mortality and rehospitalization in pa...
متن کاملDying With a Left Ventricular Assist Device as Destination Therapy.
BACKGROUND Despite the ability of left ventricular assist device as destination therapy (DT-LVAD) to prolong survival for many patients with advanced heart failure, little is known about the eventual end-of-life care that patients with DT-LVAD receive. METHODS AND RESULTS All patients undergoing DT-LVAD at the Mayo Clinic in Rochester, Minnesota, from January 1, 2007, to September 30, 2014, w...
متن کاملVentricular Assist Device-Specific Infections
Ventricular assist devices (VADs) have been shown to offer a significant survival benefit over medical therapy in patients with advanced heart failure. Despite significant advances in device technology and surgical technique, VAD-specific infections still remain among the most common causes of morbidity and mortality in patients with VADs. VAD-specific infections may involve the driveline exit ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiovascular Therapeutics
سال: 2009
ISSN: 1755-5914,1755-5922
DOI: 10.1111/j.1755-5922.2009.00081.x